WHAT THE HUMAN DATA SAY
Evidence before enthusiasm.
Early randomized trials report safety, biomarker changes and selected muscle-endurance improvements, but not broad rejuvenation or lifespan extension.
This grade reflects clinically meaningful human evidence for the use described here. It is not a score for popularity, mechanism, animal lifespan results or the number of products already being sold.
HOW IT FITS
A practical role—without pretending it is universal.
Keep exercise as the primary mitochondrial intervention. Consider urolithin A only when the cost, product quality and specific performance question justify a monitored trial.
TRACK WHAT MATTERS
Know whether it is creating value.
Repeatable endurance or function test
Training load and recovery
Product dose, batch and tolerance
SAFETY & BOUNDARIES
What should make you pause.
- Long-term outcome data remain limited.
- Pregnancy, active treatment or complex disease warrants clinician review.
BOOK CONNECTIONS
Where this idea enters the longevity conversation.
Book inclusion explains why the idea is culturally important; the evidence grade above determines how strongly The Modern Bio treats the claim.